Based on its proprietary LentiFlash® technology and Vectalys manufacturing platform, the company has potential to enable and advance the development of treatments mediated by RNA and DNA delivery for a broad range of diseases, including cancer, infectious disease and genetic diseases.
FLASH THERAPEUTICS
Address :
3 Avenue Hubert Curien Centre d'innovation Langlade31100 Toulouse
Category : PME
Business focus(es): Medicine
Theme(s): Cardiometabolism and associated risks | Dermatology | Hematophilia | Infectiology | Neurology | oncologists | Pneumology
For more information
Mme Pascale BOUILLE
pascale.bouille@flashtherapeutics.comhttps://www.flashtherapeutics.com/